Here, we demonstrate that the ability to suppress the percentage of TIM-3 positivity following the activation of CD4+ and CD8+ T cells, as well as NK cells, from glioblastoma patients is significantly reduced, and that these cells display reduced BAT3, CD69, and IFNγ expression compared to healthy donors. This evidence concerns the gene CD4 and glioblastoma.